• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    CNS Pharmaceuticals, Inc. - Common Stock (NQ:CNSP)

    8.900 +0.250 (+2.89%)
    Streaming Delayed Price Updated: 3:57 PM EDT, Sep 26, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about CNS Pharmaceuticals, Inc. - Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    Dow Dips 150 Points; US Housing Starts Fall In January
     
    Via Benzinga
    Topics Stocks
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Announces 1-for-50 Reverse Stock Split
    Via Investor Brand Network
    CNS Pharmaceuticals, Inc. Participates in the Virtual Investor “Top 5 for ‘25” On-Demand Conference
    Via ACCESS Newswire
    CNS Pharmaceuticals Announces Reverse Stock Split
    Via ACCESS Newswire
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present at 6th Glioblastoma Drug Development Summit
    Via Investor Brand Network
    CNS Pharmaceuticals to Present at the BIO CEO & Investor Conference
    Via ACCESS Newswire
    CNS Pharmaceuticals to Host Virtual Analyst & Investor Day on December 11, 2024
    Via ACCESSWIRE
    CNS Pharmaceuticals Reports Third Quarter 2024 Financial Results
    Via ACCESSWIRE
    CNS Pharmaceuticals to Present at 6th Glioblastoma Drug Development Summit
    Via ACCESS Newswire
    Check out the stocks that are attracting the most attention and driving market activity.
    Let's dive into the action on the US markets on Friday. Here are the most active stocks that are driving the market today. 
    Via Chartmill
    What's going on in today's session
    Here are the top movers in Friday's session, showcasing the stocks with significant price changes. 
    Via Chartmill
    Friday's session: gap up and gap down stocks
    The market is filled with gapping stocks in Friday's session. Let's discover which stocks are showing gap-ups and gap-downs. 
    Via Chartmill
    New Graphene Chip Could Revolutionize Brain Cancer Treatment
    Via Investor Brand Network
    Top movers in Friday's pre-market session
    Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
    Via Chartmill
    12 Health Care Stocks Moving In Friday's Pre-Market Session
     
    Via Benzinga
    Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
     
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Pre-Market Session
     
    Via Benzinga
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO to Present at BIO CEO & Investor Conference
    Via Investor Brand Network
    Study Reveals Insights into How Needed Treatments Can Bypass the Blood-Brain Barrier
    Via Investor Brand Network
    Chinese Research Team Suggests Common Drug for Blood Pressure Could Treat Invasive Brain Tumor
    Via Investor Brand Network
    12 Health Care Stocks Moving In Monday's Pre-Market Session
     
    Via Benzinga
    Research Shows Brain Tumors Grow by Hijacking Circadian Clocks
    Via Investor Brand Network
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Host Virtual Analyst & Investor Day on December 11
    Via Investor Brand Network
    AI Model Promises New Way to Detect Brain Malignancies
    Via Investor Brand Network
    Topics Artificial Intelligence Death
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Presents Progress in Pivotal Study of Berubicin for Glioblastoma Treatment
    Via Investor Brand Network
    CNS Pharmaceuticals Presents Update from Ongoing Potentially Pivotal Study of Berubicin Compared with Lomustine in Adult Patients with Recurrent GBM (WHO Grade IV) After Failure of Standard First Line Therapy
    Via ACCESSWIRE
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) to Present Berubicin Trial Update at Society for Neuro-Oncology Annual Meeting
    Via Investor Brand Network
    CNS Pharmaceuticals Announces Abstract Accepted for Poster Presentation at the 29th Annual Meeting of the Society for Neuro-Oncology (SNO 2024)
    Via ACCESSWIRE
    BioMedNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Advances Glioblastoma Treatment with Berubicin Amid Strong Financial Position
    Via Investor Brand Network
    BioMedNewsBreaks — CNS Pharmaceuticals Inc. (NASDAQ: CNSP) Highlights Berubicin’s Potential in Glioblastoma Treatment During KOL Connect Event
    Via Investor Brand Network
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    20 21 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms Of Service.